Convertible Preferred Stock and Stockholders' Equity (Deficit) - Summary of the Status of the Options Issued Under the Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Options Outstanding, Balance at December 31, 2021	6,591,727
Options Outstanding, Granted	1,639,487
Options Outstanding, Exercised (including early)	(297,726)
Forfeited	(135,967)
Options Outstanding, Balance at June 30, 2022	7,797,521	6,591,727
Options Outstanding, Vested and expected to vest as of June 30, 2022	7,797,521
Options Outstanding, Vested and exercisable at June 30, 2022	2,019,466
Weighted average exercise price per share, Balance at December 31, 2021	$ 8.04
Weighted average exercise price per share, Granted	15.32
Weighted average exercise price per share, Exercised (including early)	0.97
Weighted average exercise price per share, Forfeited	13.01
Weighted average exercise price per share, Balance at June 30, 2022	9.76	$ 8.04
Weighted average exercise price per share, Vested and expected to vest as of June 30, 2022	9.76
Weighted average exercise price per share, Vested and exercisable at June 30, 2022	$ 6.12
Weighted average remaining contractual term (Years)	8 years 4 months 13 days	9 years 3 months 3 days
Weighted average remaining contractual term, Vested and expected to vest as of June 30, 2022	8 years 4 months 13 days
Weighted average remaining contractual term, Vested and exercisable at June 30, 2022	6 years 4 months 24 days
Aggregate intrinsic value, Exercised (including early)	$ 4,298
Aggregate intrinsic value, Balance at June 30, 2022	6,333
Vested and expected to vest as of June 30, 2022	6,333
Aggregate intrinsic value, Vested and exercisable at June 30, 2022	$ 1,945